Officials for the Boston University Medical Center announced on Monday that it will join the Parkinson’s Progression Markers Initiative’s newly expanded study of uncommon risk factors of Parkinson’s ...

Parkinson’s Disease Causes, Symptoms, and Treatment Parkinson’s disease (PD) is one of the fastest-growing neurological ...

The diagnosis came like an uninvited guest that refuses to leave. Parkinson’s disease. The words hang in the air, heavy with implications about the future. But here’s something your doctor might not ...

In a recent study published in the journal Nature Medicine, a large, international team of researchers conducted an exploratory analysis to evaluate whether the monoclonal antibody prasinezumab, which ...

Although there are still some aspects pending confirmation for its use in the clinical setting, and its resolution needs to be improved slightly, a study has shown that a method routinely used to ...

A small study has found lixisenatide, a GLP-1 made by Sanofi, may slow the progression of Parkinson’s disease, according to findings published April 3 in The New England Journal of Medicine. The phase ...

Scott Rider of South Carolina is one of over 1 million people in the United States with Parkinson's disease. Working closely ...

An older diabetes treatment called lixisenatide resulted in less progression of motor disability after 12 months in patients in an early stage of the disease Erin Clack is a Staff Editor for PEOPLE.